These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation: implications for restenosis during percutaneous coronary intervention. Day JR, Malik IS, Weerasinghe A, Poullis M, Nadra I, Haskard DO, Taylor KM, Landis RC. Heart; 2004 Jul; 90(7):794-9. PubMed ID: 15201252 [Abstract] [Full Text] [Related]
17. Different effects of various anti-GPIIb-IIIa agents on shear-induced platelet activation and expression of procoagulant activity. Goto S, Tamura N, Li M, Handa M, Ikeda Y, Handa S, Ruggeri ZM. J Thromb Haemost; 2003 Sep 17; 1(9):2022-30. PubMed ID: 12941046 [Abstract] [Full Text] [Related]
18. IIb's are not IIb's. Kereiakes DJ, Runyon JP, Broderick TM, Shimshak TM. Am J Cardiol; 2000 Apr 27; 85(8A):23C-31C. PubMed ID: 10793177 [Abstract] [Full Text] [Related]
19. Differential antiplatelet efficacy for various GPIIb/IIIa antagonists: role of plasma calcium levels. Mousa SA, Bozarth JM, Forsythe MS, Slee A. Cardiovasc Res; 2000 Sep 27; 47(4):819-26. PubMed ID: 10974231 [Abstract] [Full Text] [Related]
20. Administration of abciximab to patients receiving tirofiban or eptifibatide: effect on platelet function. Lev EI, Osende JI, Richard MF, Robbins JA, Delfin JA, Rodriguez O, Sharma SK, Jayasundera T, Badimon JJ, Marmur JD. J Am Coll Cardiol; 2001 Mar 01; 37(3):847-55. PubMed ID: 11693761 [Abstract] [Full Text] [Related] Page: [Next] [New Search]